Northwest Kinetics Report issue

For profit Phase 2
Founded: Tacoma WA United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2006
NCT00154167
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

Northwest Kinetics

Active Ingredients

Drugs in Phase 2 Trials (2)

heat-labile enterotoxin of e. coli (1 trial)

phentolamine mesylate (regitine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diarrhea (Phase 2)

Hypesthesia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2